"Diagnosis and treatment standards" and "diagnosis and treatment guidelines" are the code of conduct that medical staff must strictly abide.

-- "Huaier Granules" has been recommend as the preferred drug by a number of authoritative "diagnosis and treatment standards" and "diagnosis and treatment guidelines".

"Diagnosis and treatment standards" are the standardized treatment measures for diseases formulated by the highest national health administrative department. It is a programmatic document for disease treatment and has the highest authority and legal status; "Diagnosis and treatment guidelines" are the specific methods and methods for disease treatment formulated by authoritative medical groups. It is a supplement and refinement of the "diagnosis and treatment standards" and is a high-level guiding document; "Expert consensus" and "expert opinion" are disease treatment opinions formulated by various professional committees and belong to the third-level medical manual. The above-mentioned diagnosis and treatment norms, diagnosis and treatment guidelines and expert consensus are not only the code of conduct that medical institutions and medical personnel must strictly abide by in carrying out clinical diagnosis and treatment, but also the main legal basis for the distinction of medical liability accidents.

The formation of diagnosis and treatment norms, diagnosis and treatment guidelines, expert consensus, and authoritative medical works requires a large number of high-quality clinical tests, scientific preliminary research, solid evidence-based medical evidence, and a large amount of clinical treatment experience. Only on the basis of accumulated large amounts of research data, and after strict expert argumentation and rigorous review, it can be transformed into authoritative diagnosis and treatment norms, diagnosis and treatment guidelines, expert consensus and medical textbooks.

At present, "Huaier Granule" has been listed in many authoritative diagnosis and treatment specifications, diagnosis and treatment guidelines, and expert consensus, and has been written into the 7th, 8th, and 9th editions of the five-year undergraduate "Surgery" textbook of national universities as a liver cancer. recommend drugs for postoperative systemic treatment. It is a great thing that a kind of traditional Chinese medicine can be included in the diagnosis and treatment standards and university textbooks by many authoritative institutions at the same time.

In 2017, "Huaier Granules" was included in the original National Health and Family Planning Commission's "Primary Liver Cancer Diagnosis and Treatment Standards". This is a programmatic and guiding document in the field of liver cancer diagnosis and treatment in China, and has the highest authority. This "specification" clearly points out that the traditional Chinese medicine "Huaier granule" has a certain role in preventing recurrence and metastasis in patients after radical resection of liver cancer. "Standard" at the same time, "Huai Er particles" in the anti-tumor treatment efficacy evaluation of Chinese medicine list as the first drug.

In 2018, "Huaier Granule" was listed in the "Guidelines for Diagnosis and Treatment of Primary Liver Cancer" issued by the Chinese Society of Clinical Oncology. The "Guidelines" regard "Huaier Granule" as the only modern traditional Chinese medicine recommend by experts of Class 1B evidence and Class II (Note: the level of evidence is 1A/1B/2A/2B/3, and the level of 1B evidence is quite high). Compared with the National Health and Family Planning Commission's "Diagnosis and Treatment Standard", it is a further supplement and refinement. If the "diagnosis and treatment standard" is compared to a textbook, then the "guide" is equivalent to a reference book.

In 2013, "Huaier granule" was listed in the expert consensus on the use of Chinese patent medicine in palliative treatment of tumor by the cancer rehabilitation and palliative care professional committee of China Anti Cancer Association. The expert consensus standardizes the rational application of Chinese patent medicine in tumor treatment and provides guidance for the use of Chinese patent medicine in tumor clinical. This "expert consensus" points out that "huaier granule" is a class B Chinese patent medicine recommend class II evidence.

In 2018, "Huaier Granules" was included in the "Clinical Practice Guidelines for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma in China" by the Interventional Physicians Branch of the Chinese Medical Doctor Association. The "Practice Guidelines" are the first interventional therapy that reflects the characteristics and needs of Chinese patients. The clinical practice guidelines have promoted the standardization and standardization of interventional therapy in the field of liver cancer in my country. The Practice Guide makes it clear that Huaier Granule is a representative drug for intervention combined with traditional Chinese medicine treatment.

In addition, as early as 2007, "Huaier Granules" was included in the "Guidelines for the Diagnosis and Treatment of Liver Cancer in Traditional Chinese Medicine" by the Chinese Society of Traditional Chinese Medicine, and Huaier was used as a recommend Chinese medicine.

There is no doubt about the ideological, authoritative and serious educational content of the textbooks of colleges and universities. The reason why "Huaier Granules" can be included in the 7th, 8th and 9th editions of the five-year undergraduate "Surgery" textbook of national colleges and universities, and as a recommend drug for systemic treatment after liver cancer surgery, thanks to its comprehensive and rigorous clinical research, it has obtained high-level and high-level evidence-based medical evidence, the effectiveness, safety and stability in the field of tumor treatment were verified.

Although "Huaier granule" has been widely recognized at home and abroad through scientific and rigorous methods, and has been recommend used in clinical practice by many domestic guidelines, it will not stop here. At present, "Huaier granule" is carrying out multi center and large sample clinical research on lung cancer, breast cancer, gastrointestinal cancer and so on. It is believed that the future of "Huaier granule" has unlimited possibilities.